{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T11:00:51Z","timestamp":1768302051044,"version":"3.49.0"},"reference-count":72,"publisher":"CSIRO Publishing","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Australian Pharmaceutical Benefits Scheme was changed on 15 January 2021 to provide people aged &amp;lt;18 years access to government-subsidised pre-exposure prophylaxis (PrEP) for HIV. This study investigated healthcare and service providers\u2019 attitudes and practices in discussing PrEP and impacts on PrEP prescribing practices, and the differences in the provision of PrEP to young adults aged &amp;gt;18\u00a0years compared with people aged &amp;lt;18\u00a0years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online cross-sectional survey, conducted February to November 2023, used purposive, convenience and snowball sampling to recruit healthcare providers eligible to prescribe PrEP (GPs, nurse practitioners) and non-prescribing healthcare\/service providers (sexual health nurses, HIV community workers) in Australia. Young people were split into three age groups for comparison between young adults (aged 18\u201324 years) and adolescents, including those above (aged 16\u201317 years) and below (&amp;lt;16 years) the age of consent in Australia. Cross-tabulation with Pearson\u2019s chi-squared and Fisher\u2019s exact tests were performed to investigate sexual health and PrEP-related attitudes and practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 122 respondents, 40.2% (49\/122) were nurses, 18.0% (22\/122) GPs, 11.5% (14\/122) HIV community workers, 11.5% (14\/122) were another profession (including public health physician, LGBTIQA child and family practitioner, social worker, counsellor), 10.7% (13\/122) were sexual health physicians, 6.6% (8\/122) nurse practitioners and two were HIV specialists. Most (73.8%, 90\/122) reported initiating PrEP conversations with 18\u201324-year-olds, compared with 13.1% (16\/122) with those aged &amp;gt;16\u00a0years. Of the 48 (39.3%) eligible PrEP prescribers, 47.9% (23\/48) reported feeling \u2018extremely\/somewhat\u2019 comfortable assessing PrEP eligibility, 41.7% (20\/48) reported awareness of 2021 Pharmaceutical Benefits Scheme changes and 18.8% (9\/48) reported changes to prescribing practices. Prescribers were significantly more likely than non-prescribers to consider PrEP suitable (54.2% vs 35.8%, P\u00a0&amp;lt;\u00a00.05) for clients aged &amp;lt;16 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Guidelines and prescribing criteria need to reflect current Pharmaceutical Benefits Scheme eligibility for young people to support healthcare prescriber decision-making in recommending and prescribing PrEP for HIV for young people where appropriate. Greater education, training and support is required for healthcare providers to improve provider confidence in discussing sexual health needs, and recommending and prescribing PrEP to young people to optimise the possible benefits of access to sexual health services and PrEP in this priority sub-group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh25172","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:26:22Z","timestamp":1764789982000},"source":"Crossref","is-referenced-by-count":0,"title":["Healthcare and service provider perspectives on pre-exposure prophylaxis for HIV among young Australians"],"prefix":"10.1071","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9149-1962","authenticated-orcid":true,"given":"Sarah","family":"Warzywoda","sequence":"first","affiliation":[{"name":"AThe University of Queensland, Faculty of Medicine, School of Public Health, Herston, Qld 4006, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalie","family":"Dyda","sequence":"additional","affiliation":[{"name":"AThe University of Queensland, Faculty of Medicine, School of Public Health, Herston, Qld 4006, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"AThe University of Queensland, Faculty of Medicine, School of Public Health, Herston, Qld 4006, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0939-9842","authenticated-orcid":true,"given":"Amy B.","family":"Mullens","sequence":"additional","affiliation":[{"name":"BUniversity of Southern Queensland, School of Psychology & Wellbeing, Centre for Health Research, Ipswich, Qld 4305, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-5250","authenticated-orcid":true,"given":"James A.","family":"Fowler","sequence":"additional","affiliation":[{"name":"AThe University of Queensland, Faculty of Medicine, School of Public Health, Herston, Qld 4006, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Coffey","sequence":"additional","affiliation":[{"name":"CQueensland Positive People (QPP), East Brisbane, Qld 4167, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Sargent","sequence":"additional","affiliation":[{"name":"CQueensland Positive People (QPP), East Brisbane, Qld 4167, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Muscolino","sequence":"additional","affiliation":[{"name":"DQueensland Council for LGBTI Health (QC), Teneriffe, Qld 4005, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Morris","sequence":"additional","affiliation":[{"name":"EOpen Doors Youth Service, Fortitude Valley, Qld 4006, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-2013","authenticated-orcid":true,"given":"Judith A.","family":"Dean","sequence":"additional","affiliation":[{"name":"AThe University of Queensland, Faculty of Medicine, School of Public Health, Herston, Qld 4006, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"5","key":"2026011222214805000_R1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"2026011222214805000_R2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"An observational study of preexposure prophylaxis uptake, sexual practices, and HIV incidence among men and transgender women who have sex with men.","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2026011222214805000_R3","unstructured":"WHO. Guidance on pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects; 2012. Available at https:\/\/www.who.int\/publications\/i\/item\/9789241503884"},{"issue":"8","key":"2026011222214805000_R4","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.1016\/S2352-3018(21)00074-6","article-title":"Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study.","volume":"8","author":"Grulich","year":"2021","journal-title":"Lancet HIV"},{"issue":"10013","key":"2026011222214805000_R5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"2026011222214805000_R6","unstructured":"Department of Health and Aged Care Therapeutic Goods Administration. Therapeutic Goods Administration (TGA). Australian Government; 2025. Available at https:\/\/www.tga.gov.au\/"},{"key":"2026011222214805000_R7","unstructured":"ASHM. PrEP. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine; 2021. Available at https:\/\/www.ashm.org.au\/HIV\/PrEP\/"},{"key":"2026011222214805000_R8","unstructured":"Grove A. The pharmaceutical benefits scheme: a quick guide. Parliament of Australia; 2021. Available at https:\/\/www.aph.gov.au\/About_Parliament\/Parliamentary_Departments\/Parliamentary_Library\/pubs\/rp\/rp1516\/Quick_Guides\/PBS [accessed 11 November 2021]"},{"key":"2026011222214805000_R9","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2022.1048702","article-title":"Improving HIV pre-exposure prophylaxis persistence among adolescent girls and young women: insights from a mixed-methods evaluation of community, hybrid, and facility service delivery models in Namibia.","volume":"4","author":"Barnabee","year":"2022","journal-title":"Front Reprod Health"},{"issue":"1","key":"2026011222214805000_R10","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11335-1","article-title":"Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.","volume":"21","author":"Jackson-Gibson","year":"2021","journal-title":"BMC Public Health"},{"issue":"3","key":"2026011222214805000_R11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213022","article-title":"Participation in community groups increases the likelihood of PrEP awareness: New Orleans NHBS-MSM Cycle, 2014.","volume":"14","author":"Ransome","year":"2019","journal-title":"PLoS ONE"},{"issue":"2","key":"2026011222214805000_R12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1071\/SH20208","article-title":"Challenges of providing HIV pre-exposure prophylaxis across Australian clinics: qualitative insights of clinicians.","volume":"18","author":"Smith","year":"2021","journal-title":"Sex Health"},{"key":"2026011222214805000_R13","unstructured":"Pharmaceutical Benefits Scheme. TENOFOVIR + EMTRICITABINE;\u00a02025. Available at https:\/\/www.pbs.gov.au\/medicine\/item\/10347N-11146P-11149T-11276L-11296M-11306C"},{"key":"2026011222214805000_R14","doi-asserted-by":"crossref","unstructured":"Chan C, Medland N, McManus H, McGregor S, Grulich A, Bavinton B. Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia (Issue 11); 2024. Available at https:\/\/www.kirby.unsw.edu.au\/sites\/default\/files\/documents\/Monitoring-HIV-pre-exposure-prohpylaxis-PrEP-uptake-in-Australia_Issue-11.pdf","DOI":"10.1016\/S2352-3018(24)00213-3"},{"issue":"11","key":"2026011222214805000_R15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamapediatrics.2017.2007","article-title":"Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States.","volume":"171","author":"Hosek","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"12","key":"2026011222214805000_R16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2352-4642(20)30248-0","article-title":"Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.","volume":"4","author":"Gill","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"2026011222214805000_R17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1743","article-title":"PrEP and adolescents: the role of providers in ending the AIDS Epidemic.","volume":"145","author":"Hosek","year":"2020","journal-title":"Pediatrics"},{"key":"2026011222214805000_R18","unstructured":"WHO. Consolidated guidlines on HIV testing services. 2015. 5Cs: Consent, Confidentiality, Counselling, Corrent Results and Connection;\u00a02015. Available at https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/179870\/9789241508926_eng.pdf;jsessionid=8D37D2E2C70F2BEA4880732730709AA7?sequence=1"},{"issue":"7","key":"2026011222214805000_R19","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25363","article-title":"Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States.","volume":"22","author":"Taggart","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2026011222214805000_R20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","article-title":"An HIV preexposure prophylaxis demonstration project and safety study for young MSM.","volume":"74","author":"Hosek","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026011222214805000_R21","unstructured":"U.S. Centres for Disease Control and Prevention. Clinical guidance for PrEP; 2025. Available at https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html"},{"key":"2026011222214805000_R22","unstructured":"Department of Health Disability and Aging Therapeutic Goods Administration. TENOFOVIR\/EMTRICITABINE 300\/200 APX Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack (327896); 2020. Available at https:\/\/www.tga.gov.au\/resources\/artg\/327896"},{"key":"2026011222214805000_R23","unstructured":"Department of Health Disability and Aging. PBS frequently asked questions. Australian Government; 2025. Available at https:\/\/www.pbs.gov.au\/info\/general\/faq"},{"key":"2026011222214805000_R24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14745\/ccdr.v51i01a05","article-title":"HIV-PrEP use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018\u20132021.","volume":"51","author":"Popovic","year":"2025","journal-title":"Can Commun Dis Rep (CCDR)"},{"key":"2026011222214805000_R25","unstructured":"National AIDS Trust. UK HIV Statistics;\u00a02024. Available at https:\/\/nat.org.uk\/about-hiv\/hiv-statistics\/#prep"},{"issue":"2","key":"2026011222214805000_R26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.33696\/aids.2.006","article-title":"Older versus younger men who have sex with men: awareness of and potential barriers to the use of Pre-Exposure Prophylaxis (PrEP) medication to prevent the transmission of HIV.","volume":"2","author":"Klein","year":"2020","journal-title":"J AIDS HIV Treat"},{"issue":"2","key":"2026011222214805000_R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.anzjph.2024.100136","article-title":"A cross-sectional investigation of the factors associated with awareness of PEP and PrEP among Queensland university students.","volume":"48","author":"Warzywoda","year":"2024","journal-title":"Aust N Z J Public Health"},{"issue":"5","key":"2026011222214805000_R28","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s10461-016-1480-0","article-title":"Exploring patterns of awareness and use of HIV pre-exposure prophylaxis among young men who have sex with men.","volume":"21","author":"Strauss","year":"2017","journal-title":"AIDS Behav"},{"issue":"5","key":"2026011222214805000_R29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064038","article-title":"Awareness and willingness to use HIV pre-exposure prophylaxis amongst gay and bisexual men in Scotland: implications for biomedical HIV prevention.","volume":"8","author":"Young","year":"2013","journal-title":"PLoS ONE"},{"key":"2026011222214805000_R30","unstructured":"King J, Kwon J, McManus H, Gray R, McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2024; 2024. Available at https:\/\/www.kirby.unsw.edu.au\/research\/reports\/asr2024"},{"issue":"12","key":"2026011222214805000_R31","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/imj.14040","article-title":"Human immunodeficiency virus-infected young people in Australia: data from the Australian HIV Observational Database.","volume":"48","author":"Hughes","year":"2018","journal-title":"Intern Med J"},{"issue":"1","key":"2026011222214805000_R32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MOP.0000000000000580","article-title":"Stopping the rise of HIV among adolescents globally.","volume":"30","author":"Rotheram-Borus","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"2026011222214805000_R33","unstructured":"Kirby Institute. HIV;\u00a02025. Available at https:\/\/data.kirby.unsw.edu.au\/hiv"},{"key":"2026011222214805000_R34","unstructured":"Australian Bureau of Statistics. National, state and territory population. ABS; 2023. Available at https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/dec-2022 [accessed 16 December 2024]"},{"issue":"6","key":"2026011222214805000_R35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1071\/SH20156","article-title":"Australian interdisciplinary healthcare providers\u2019 perspectives on the effects of broader pre-exposure prophylaxis (PrEP) access on uptake and service delivery: a qualitative study.","volume":"17","author":"Lazarou","year":"2020","journal-title":"Sex Health"},{"key":"2026011222214805000_R36","doi-asserted-by":"publisher","DOI":"10.1177\/20499361241303415","article-title":"Pre-exposure prophylaxis access, uptake and usage by young people: a systematic review of barriers and facilitators.","volume":"11","author":"Warzywoda","year":"2024","journal-title":"Ther Adv Infect Dis"},{"issue":"2","key":"2026011222214805000_R37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jadohealth.2018.03.016","article-title":"Adolescent health providers\u2019 willingness to prescribe pre-exposure prophylaxis (PrEP) to youth at risk of HIV infection in the United States.","volume":"63","author":"Hart-Cooper","year":"2018","journal-title":"J Adolesc Health"},{"issue":"7","key":"2026011222214805000_R38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/apc.2016.0048","article-title":"Adolescent human immunodeficiency virus care providers\u2019 attitudes toward the use of oral pre-exposure prophylaxis in youth.","volume":"30","author":"Mullins","year":"2016","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"2026011222214805000_R39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jadohealth.2023.02.007","article-title":"Implementation factors associated with primary care providers\u2019 intention to prescribe HIV PrEP to adolescents in the United States.","volume":"73","author":"Owens","year":"2023","journal-title":"J Adolesc Health"},{"issue":"10","key":"2026011222214805000_R40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/apc.2021.0045","article-title":"Provider comfort with prescribing HIV pre-exposure prophylaxis to adolescents.","volume":"35","author":"Pina","year":"2021","journal-title":"AIDS Patient Care STDS"},{"key":"2026011222214805000_R41","doi-asserted-by":"publisher","DOI":"10.1071\/SH24018","article-title":"Prescribing pre-exposure prophylaxis for HIV prevention: a cross-sectional survey of general practitioners in Australia.","volume":"21","author":"Wu","year":"2024","journal-title":"Sex Health"},{"issue":"4","key":"2026011222214805000_R42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/09540121.2018.1500007","article-title":"Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners\u2019 practices and attitudes.","volume":"31","author":"Bell","year":"2019","journal-title":"AIDS Care"},{"issue":"1","key":"2026011222214805000_R43","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-021-01376-1","article-title":"A survey of the involvement of primary care doctors in HIV prevention and care in a low-prevalence, high-income setting.","volume":"22","author":"Tam","year":"2021","journal-title":"BMC Fam Pract"},{"issue":"11","key":"2026011222214805000_R44","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1007\/s10389-021-01626-7","article-title":"A cross-sectional survey of general practitioner knowledge, attitudes, and clinical experience of HIV PrEP.","volume":"30","author":"North","year":"2022","journal-title":"J Public Health"},{"key":"2026011222214805000_R45","unstructured":"Qualtrics; 2020. Available at https:\/\/www.qualtrics.com"},{"issue":"12","key":"2026011222214805000_R46","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/apc.2017.0147","article-title":"HIV care providers\u2019 intentions to prescribe and actual prescription of pre-exposure prophylaxis to at-risk adolescents and adults.","volume":"31","author":"Mullins","year":"2017","journal-title":"AIDS Patient Care STDS"},{"key":"2026011222214805000_R47","unstructured":"Australian Institute of Family Studies. Age of consent laws. Australian Institute of Family Studies; 2021. Available at https:\/\/aifs.gov.au\/cfca\/publications\/age-consent-laws [accessed 17 March 2021]"},{"key":"2026011222214805000_R48","unstructured":"Stata Statistical Software: Release 17. StataCorp LLC; 2021."},{"key":"2026011222214805000_R49","unstructured":"ASHM. PrEP guidelines update. Prevent HIV by prescribing PrEP; 2023. Available at https:\/\/ashm.org.au\/wp-content\/uploads\/2024\/01\/ASHM-Health_PrEP-Guidelines.pdf"},{"issue":"4","key":"2026011222214805000_R50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jadohealth.2018.07.021","article-title":"HIV pre-exposure prophylaxis medication for adolescents and young adults: a position paper of the society for adolescent health and medicine.","volume":"63","author":"Society for Adolescent Health and Medicine","year":"2018","journal-title":"J Adolesc Health"},{"issue":"3","key":"2026011222214805000_R51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.pedhc.2018.09.007","article-title":"Adolescent preexposure prophylaxis administration: an education curriculum for health care providers.","volume":"33","author":"Carnevale","year":"2019","journal-title":"J Pediatr Health Care"},{"key":"2026011222214805000_R52","unstructured":"Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM). ASHM Health National PrEP Guidelines Update. Prevent HIV by Prescribing PrEP; 2025. Available at https:\/\/ashm.org.au\/wp-content\/uploads\/2025\/08\/ASHM-PrEP-guidelines-2025_FINAL.pdf"},{"issue":"4","key":"2026011222214805000_R53","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/ciz486","article-title":"Changes in bone mass after discontinuation of preexposure prophylaxis with tenofovir disoproxil fumarate\/emtricitabine in young men who have sex with men: extension phase results of adolescent trials network protocols 110 and 113.","volume":"70","author":"Havens","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026011222214805000_R54","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.749948","article-title":"Vitamin D and calcium supplementation reverses tenofovir-caused bone mineral density loss in people taking ART or PrEP: a systematic review and meta-analysis.","volume":"9","author":"Bi","year":"2022","journal-title":"Front Nutr"},{"issue":"2","key":"2026011222214805000_R55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-049411","article-title":"Sexual and reproductive health discussions during preventive visits.","volume":"148","author":"Sieving","year":"2021","journal-title":"Pediatrics"},{"issue":"2","key":"2026011222214805000_R56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11195-019-09597-0","article-title":"Sexual health communication between healthcare professionals and adolescents with chronic conditions in western countries: an integrative review.","volume":"38","author":"Engelen","year":"2020","journal-title":"Sex Disabil"},{"key":"2026011222214805000_R57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.childyouth.2018.05.025","article-title":"Sexual health conversations: predicting the odds of HIV testing among black youth and young adults.","volume":"90","author":"Boyd","year":"2018","journal-title":"Child Youth Serv Rev"},{"key":"2026011222214805000_R58","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101335","article-title":"Re-imagine an AIDS free generation: examining youth and young adults\u2019 personal agency and its association with HIV testing.","volume":"22","author":"Boyd","year":"2021","journal-title":"Prev Med Rep"},{"issue":"9","key":"2026011222214805000_R59","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.pec.2016.06.004","article-title":"\u201cI just think that doctors need to ask more questions\u201d: sexual minority and majority adolescents\u2019 experiences talking about sexuality with healthcare providers.","volume":"99","author":"Fuzzell","year":"2016","journal-title":"Patient Educ Couns"},{"issue":"11","key":"2026011222214805000_R60","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1111\/j.1743-6109.2012.02856.x","article-title":"Why don\u2019t healthcare professionals talk about sex? a systematic review of recent qualitative studies conducted in the United Kingdom.","volume":"10","author":"Dyer","year":"2013","journal-title":"J Sex Med"},{"key":"2026011222214805000_R61","unstructured":"ASHM. Prescribing HIV Pre-Exposure Prophylaxis (PrEP) in Australia. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM); 2018."},{"issue":"11","key":"2026011222214805000_R62","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1080\/09540121.2020.1822502","article-title":"Tools to measure HIV knowledge, attitudes & practices (KAPs) in healthcare providers: a systematic review.","volume":"33","author":"Kaladharan","year":"2021","journal-title":"AIDS Care"},{"issue":"4","key":"2026011222214805000_R63","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1071\/SH22193","article-title":"Syphilis in pregnancy: a qualitative investigation of healthcare provider perspectives on barriers to syphilis screening during pregnancy in south-east Queensland.","volume":"20","author":"Warzywoda","year":"2023","journal-title":"Sex Health"},{"issue":"4","key":"2026011222214805000_R64","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taae024","article-title":"Integrating sexual and reproductive health into pre-travel consultations.","volume":"31","author":"Santaolaya","year":"2024","journal-title":"J Travel Med"},{"issue":"1","key":"2026011222214805000_R65","doi-asserted-by":"publisher","DOI":"10.1071\/SH23098","article-title":"The provision of sexual and reproductive health information and services to travellers: an exploratory survey of Australian travel medicine clinicians.","volume":"21","author":"Warzywoda","year":"2024","journal-title":"Sex Health"},{"key":"2026011222214805000_R66","unstructured":"Gardiner FW, Bishop L, de Graaf B, Campbell JA, Gale L, Quinlan F. Equitable patient access to primary healthcare in Australia. The Royal Flying Doctor Service of Australia; 2020."},{"issue":"11","key":"2026011222214805000_R67","doi-asserted-by":"publisher","first-page":"632","DOI":"10.5694\/mja14.00160","article-title":"Engaging Aboriginal and Torres Strait Islander men in primary care settings.","volume":"200","author":"Wenitong","year":"2014","journal-title":"Med J Aust"},{"issue":"4","key":"2026011222214805000_R68","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/13691058.2016.1233354","article-title":"Drawing them in: professional perspectives on the complexities of engaging \u2018culturally diverse\u2019 young people with sexual and reproductive health promotion and care in Sydney, Australia.","volume":"19","author":"Botfield","year":"2017","journal-title":"Cult Health Sex"},{"issue":"8","key":"2026011222214805000_R69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/apc.2023.0090","article-title":"Implementation facilitators and barriers for primary care providers prescribing daily oral PrEP to adolescents in the United States.","volume":"37","author":"Owens","year":"2023","journal-title":"AIDS Patient Care STDS"},{"issue":"13","key":"2026011222214805000_R70","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1080\/00918369.2022.2092804","article-title":"Fostering Gender-IQ: barriers and enablers to gender-affirming behavior amongst an australian general practitioner cohort.","volume":"70","author":"Franks","year":"2023","journal-title":"J Homosex"},{"issue":"1","key":"2026011222214805000_R71","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-023-04373-3","article-title":"LGBTQ+ cultural competency training for health professionals: a systematic review.","volume":"23","author":"Yu","year":"2023","journal-title":"BMC Med Educ"},{"issue":"5","key":"2026011222214805000_R72","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jadohealth.2018.10.300","article-title":"Primary care physician attitudes and intentions toward the use of HIV pre-exposure prophylaxis in adolescents in one metropolitan region.","volume":"64","author":"Mullins","year":"2019","journal-title":"J Adolesc Health"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25172\/1836542\/sh25172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25172\/1836542\/sh25172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:22:04Z","timestamp":1768274524000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/23\/1\/SH25172\/267147\/Healthcare-and-service-provider-perspectives-on"}},"subtitle":[],"editor":[{"given":"Anthony","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,5]]}},"URL":"https:\/\/doi.org\/10.1071\/sh25172","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"SH25172"}}